Neurostimulation Devices Market: Global Industry Size, Growth, Share and Forecast to 2025

Published By: Brisk Insights | Published On: Jun 7, 2017

Key Findings

The Global Neurostimulation Devices Market has been projected to grow at the CAGR of 13.15% during 2017-2025. In 2016, the market has generated the revenue of $ 5,898.5 million and is expected to reach $ 18,156.5 million in terms of revenue by 2025.


Neurostimulation involves modulation or stimulation of neural processes. Growth in geriatric population, incidence of chronic pain, neurological diseases such as Parkinson’s disease and Alzheimer’s disease have presented significant proliferation opportunities for neurostimulation devices. In the future, it is expected that the progress of the neurostimulation devices market will be facilitated by utilization of the lucrative opportunities present in emerging markets of Middle East and Africa, Latin America and Asia Pacific, and further evolution of implantable devices.


Market Segment Insights

Based on the therapeutic areas, the global neurostimulation devices market is segmented into epilepsy, essential tremor, depression, dystonia, pain management, urinary and fecal incontinence, Parkinson’s disease, gastroparesis and others. Among these, pain management is anticipated to remain the largest segment through the forecast period. Furthermore, the Parkinson’s disease segment is anticipated to progress at the fastest CAGR due to improving success rate of neurostimulation devices in treating neurological conditions. Other conditions such as epilepsy, migraine etc. are anticipated to attract more attention from patients and physicians for neurostimulation treatments majorly due to rising patient population in this category.


Deep brain stimulators, spinal cord stimulations, gastric electric stimulators, vagus nerve stimulators and sacral nerve stimulators studied in the scope of this report. The market size of spinal cord stimulation is observed to be the largest among the considered stimulation types. Wide therapeutic application of spinal cord stimulation and intense market penetration are the key factors contributing to the dominance of spinal cord stimulators segment. Further technological innovation and expansion in therapeutic scope will augment the reach of this segment during the forecast period. On the other hand, deep brain stimulators are anticipated to be rapidly adopted in the global market particularly for treating peculiar neurological conditions.


Regional Insights

Based on regional distribution, the global neurostimulation devices market is categorized into North America (U.S., Canada), Europe (U.K., Germany, Rest of Europe), Asia Pacific (Japan, China, Rest of Asia Pacific), Latin America (Brazil, Mexico, Rest of Latin America) and Middle East and Africa (Saudi Arabia, South Africa, Rest of MEA). Among the considered regional markets, North America accounted for the largest share followed by Europe. Significant unmet needs in Middle East and Africa and Asia Pacific will attract the attention of manufacturers of neurostimulation devices. Increase in healthcare expenditure, evolution of healthcare infrastructure and growing availability of skilled personnel in these regions are anticipated to be the most significant drivers.


Market Competition Assessment:

The major players currently operating in the global neurostimulation devices market include Boston Scientific Corporation, Cyberonics, Cogentix Medical, Codman & Shurtleff, Inc., IntraPace, Inc., Medtronic, Nevro Corp., Neuronetics, Inc., St. Jude Medical and others.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Neurostimulation Devices Market Portraiture
2.2 Global Neurostimulation Devices Market, by Type, 2016
2.3 Global Neurostimulation Devices Market, by Therapeutic Area, 2016
2.4 Global Neurostimulation Devices Market Share, by Geography, 2016

Chapter 3 Global Neurostimulation Devices Market Overview
3.1 Overview
3.2 Market Dynamics
3.2.1 Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Market Competition Assessment: Neurostimulation Devices Market, by Key Players

Chapter 4 Global Neurostimulation Devices Market, By Type, 2015-2025 ($ Million)
4.1 Introduction
4.2 Spinal Cord Stimulators
4.3 Deep Brain Stimulators
4.4 Sacral Nerve Stimulators
4.5 Vagus Nerve Stimulators
4.6 Gastric Electric Stimulators

Chapter 5 Global Neurostimulation Devices Market, By Therapeutic Areas, 2015-2025 ($ Million)
5.1 Introduction
5.2 Pain Management
5.3 Epilepsy
5.4 Essential Tremors
5.5 Urinary and Fecal Incontinence
5.6 Depression
5.7 Dystonia
5.8 Gastroparesis
5.9 Parkinson’s Disease
5.10 Others

Chapter 6 Global Neurostimulation Devices Market, By Geography, 2015-2025 ($ Million)
6.1 Preface
6.2 North America (U.S., Canada)
6.3 Europe (U.K., Germany, Rest of Europe)
6.4 Asia Pacific (Japan, China, Rest of Asia Pacific)
6.5 Latin America (Brazil, Mexico, Rest of LATAM)
6.6 Middle East and Africa (Saudi Arabia, South Africa, Rest of MEA)

Chapter 7 Company Profiles
7.1 Medtronic
7.2 St. Jude Medical
7.3 Boston Scientific Corporation
7.4 Cyberonics
7.5 Nevro Corp
7.6 Cogentix Medical
7.7 Neuronetics, Inc.
7.8 IntraPace, Inc.
7.9 Codman & Shurtleff, Inc.
7.10 Other Major Players



Choose License

Contact Information

: 24/7 Research Support


: +448081890034 (UK)